↓ Skip to main content

Taylor and Francis Online

Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study

Overview of attention for article published in Leukemia & Lymphoma, August 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
patent
1 patent

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
54 Mendeley
Title
Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study
Published in
Leukemia & Lymphoma, August 2011
DOI 10.3109/10428194.2011.606382
Pubmed ID
Authors

Haifa K. Al-Ali, Nadja Jaekel, Christian Junghanss, Georg Maschmeyer, Rainer Krahl, Michael Cross, Gisa Hoppe, Dietger Niederwieser

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Germany 1 2%
Peru 1 2%
Unknown 51 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 17%
Student > Ph. D. Student 7 13%
Student > Doctoral Student 7 13%
Other 4 7%
Professor > Associate Professor 4 7%
Other 10 19%
Unknown 13 24%
Readers by discipline Count As %
Medicine and Dentistry 29 54%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Nursing and Health Professions 1 2%
Other 2 4%
Unknown 14 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2020.
All research outputs
#3,110,881
of 23,804,991 outputs
Outputs from Leukemia & Lymphoma
#188
of 4,094 outputs
Outputs of similar age
#15,696
of 125,890 outputs
Outputs of similar age from Leukemia & Lymphoma
#1
of 32 outputs
Altmetric has tracked 23,804,991 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,094 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,890 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.